Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-029188
Filing Date
2017-05-24
Accepted
2017-05-24 08:49:59
Documents
4
Period of Report
2017-06-27
Effectiveness Date
2017-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A v467708_def14a.htm DEF 14A 769045
2 GRAPHIC pg28img1_def14a.jpg GRAPHIC 87347
3 GRAPHIC proxy01_def14a.jpg GRAPHIC 155971
4 GRAPHIC proxy02_def14a.jpg GRAPHIC 122646
  Complete submission text file 0001144204-17-029188.txt   1274877
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32295 | Film No.: 17865539
SIC: 2836 Biological Products, (No Diagnostic Substances)